Kurosawa, T.; Tega, Y.; Uchida, Y.; Higuchi, K.; Tabata, H.; Sumiyoshi, T.; Kubo, Y.; Terasaki, T.; Deguchi, Y.
Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier. Pharmaceutics 2022, 14, 1683.
https://doi.org/10.3390/pharmaceutics14081683
AMA Style
Kurosawa T, Tega Y, Uchida Y, Higuchi K, Tabata H, Sumiyoshi T, Kubo Y, Terasaki T, Deguchi Y.
Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier. Pharmaceutics. 2022; 14(8):1683.
https://doi.org/10.3390/pharmaceutics14081683
Chicago/Turabian Style
Kurosawa, Toshiki, Yuma Tega, Yasuo Uchida, Kei Higuchi, Hidetsugu Tabata, Takaaki Sumiyoshi, Yoshiyuki Kubo, Tetsuya Terasaki, and Yoshiharu Deguchi.
2022. "Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier" Pharmaceutics 14, no. 8: 1683.
https://doi.org/10.3390/pharmaceutics14081683
APA Style
Kurosawa, T., Tega, Y., Uchida, Y., Higuchi, K., Tabata, H., Sumiyoshi, T., Kubo, Y., Terasaki, T., & Deguchi, Y.
(2022). Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier. Pharmaceutics, 14(8), 1683.
https://doi.org/10.3390/pharmaceutics14081683